References |
Top |
REF 1 |
Interaction of Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) and Vav3 in the Receptor Activator of Nuclear Factor B (RANK) Signaling Complex Enhances Osteoclastogenesis. J Biol Chem. 2016 Sep 23;291(39):20643-60.
|
REF 2 |
Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol. 2007;3:89.
|
REF 3 |
The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-kappaB activation at the level of TRAF6. FEBS Lett. 1999 Jan 15;442(2-3):147-50.
|
REF 4 |
Endotoxin tolerance impairs IL-1 receptor-associated kinase (IRAK) 4 and TGF-beta-activated kinase 1 activation, K63-linked polyubiquitination and assembly of IRAK1, TNF receptor-associated factor 6, and IkappaB kinase gamma and increases A20 expression. J Biol Chem. 2011 Mar 11;286(10):7905-16.
|
REF 5 |
Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20. J Mol Biol. 2008 Feb 15;376(2):526-40.
|
REF 6 |
Isolation and characterization of two novel A20-like proteins. Biochem J. 2001 Aug 1;357(Pt 3):617-23.
|
REF 7 |
The deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling. Sci Signal. 2013 Jun 4;6(278):ra44.
|
REF 8 |
YOD1/TRAF6 association balances p62-dependent IL-1 signaling to NF-B. Elife. 2017 Feb 28;6. pii: e22416.
|
REF 9 |
OTUB1 modulates c-IAP1 stability to regulate signalling pathways. EMBO J. 2013 Apr 17;32(8):1103-14.
|
REF 10 |
K63-linked polyubiquitination of transcription factor IRF1 is essential for IL-1-induced production of chemokines CXCL10 and CCL5. Nat Immunol. 2014 Mar;15(3):231-8.
|
REF 11 |
Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46.
|
REF 12 |
Systematic analysis of dimeric E3-RING interactions reveals increased combinatorial complexity in human ubiquitination networks. Mol Cell Proteomics. 2012 Jul;11(7):M111.016162.
|
REF 13 |
Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity. 2011 Sep 23;35(3):426-40.
|
REF 14 |
Peg3/Pw1 is an imprinted gene involved in the TNF-NFkappaB signal transduction pathway. Nat Genet. 1998 Mar;18(3):287-91.
|
REF 15 |
The atypical PKC-interacting protein p62 channels NF-kappaB activation by the IL-1-TRAF6 pathway. EMBO J. 2000 Apr 3;19(7):1576-86.
|
REF 16 |
K63 polyubiquitination and activation of mTOR by the p62-TRAF6 complex in nutrient-activated cells. Mol Cell. 2013 Aug 8;51(3):283-96.
|
REF 17 |
TRAF6 and p62 inhibit amyloid -induced neuronal death through p75 neurotrophin receptor. Neurochem Int. 2012 Dec;61(8):1289-93.
|
REF 18 |
Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. Mol Cell Biol. 2004 Sep;24(18):8055-68.
|
REF 19 |
The signaling adapter p62 is an important mediator of T helper 2 cell function and allergic airway inflammation. EMBO J. 2006 Aug 9;25(15):3524-33.
|
REF 20 |
DEAD Box Protein 5 Inhibits Liver Tumorigenesis by Stimulating Autophagy via Interaction with p62/SQSTM1. Hepatology. 2019 Mar;69(3):1046-1063.
|
REF 21 |
PB1 domain interaction of p62/sequestosome 1 and MEKK3 regulates NF-kappaB activation. J Biol Chem. 2010 Jan 15;285(3):2077-89.
|
REF 22 |
A20-binding inhibitor of NF-B (ABIN1) controls Toll-like receptor-mediated CCAAT/enhancer-binding protein activation and protects from inflammatory disease. Proc Natl Acad Sci U S A. 2011 Nov 1;108(44):E998-1006.
|
REF 23 |
Functional studies for the TRAF6 mutation associated with hypohidrotic ectodermal dysplasia. Br J Dermatol. 2013 Mar;168(3):629-33.
|
REF 24 |
A proteome-scale map of the human interactome network. Cell. 2014 Nov 20;159(5):1212-1226.
|
REF 25 |
Hsp70 inhibits lipopolysaccharide-induced NF-kappaB activation by interacting with TRAF6 and inhibiting its ubiquitination. FEBS Lett. 2006 May 29;580(13):3145-52.
|
REF 26 |
A Method to Identify p62's UBA Domain Interacting Proteins. Biol Proced Online. 2003;5:228-237.
|
REF 27 |
TRAF6 is a signal transducer for interleukin-1. Nature. 1996 Oct 3;383(6599):443-6.
|
REF 28 |
A novel splice variant of interleukin-1 receptor (IL-1R)-associated kinase 1 plays a negative regulatory role in Toll/IL-1R-induced inflammatory signaling. Mol Cell Biol. 2005 Aug;25(15):6521-32.
|
REF 29 |
Brazilin selectively disrupts proximal IL-1 receptor signaling complex formation by targeting an IKK-upstream signaling components. Biochem Pharmacol. 2014 Jun 15;89(4):515-25.
|
REF 30 |
IRAK1b, a novel alternative splice variant of interleukin-1 receptor-associated kinase (IRAK), mediates interleukin-1 signaling and has prolonged s... J Biol Chem. 2001 Aug 3;276(31):29037-44.
|
REF 31 |
T6BP, a TRAF6-interacting protein involved in IL-1 signaling. Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9567-72.
|
REF 32 |
IL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK). Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4461-5.
|
REF 33 |
Down syndrome candidate region-1 protein interacts with Tollip and positively modulates interleukin-1 receptor-mediated signaling. Biochim Biophys Acta. 2009 Dec;1790(12):1673-80.
|
REF 34 |
Variant IL-1 receptor-associated kinase-1 mediates increased NF-kappa B activity. J Immunol. 2007 Sep 15;179(6):4125-34.
|
REF 35 |
PINK1 positively regulates IL-1-mediated signaling through Tollip and IRAK1 modulation. J Neuroinflammation. 2012 Dec 17;9:271.
|
REF 36 |
IRAK-4: a novel member of the IRAK family with the properties of an IRAK-kinase. Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5567-72.
|
REF 37 |
IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family. J Biol Chem. 1999 Jul 2;274(27):19403-10.
|
REF 38 |
TRIM38 inhibits TNF- and IL-1-triggered NF-B activation by mediating lysosome-dependent degradation of TAB2/3. Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):1509-14.
|
REF 39 |
Identification of TIFA as an adapter protein that links tumor necrosis factor receptor-associated factor 6 (TRAF6) to interleukin-1 (IL-1) receptor-associated kinase-1 (IRAK-1) in IL-1 receptor signaling. J Biol Chem. 2003 Apr 4;278(14):12144-50.
|
REF 40 |
IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science. 1997 Nov 28;278(5343):1612-5.
|
REF 41 |
Syntenin negatively regulates TRAF6-mediated IL-1R/TLR4 signaling. Cell Signal. 2008 Apr;20(4):666-74.
|
REF 42 |
IRAK-1-mediated negative regulation of Toll-like receptor signaling through proteasome-dependent downregulation of TRAF6. Biochim Biophys Acta. 2012 Feb;1823(2):255-63.
|
REF 43 |
Pellino 1 is required for interleukin-1 (IL-1)-mediated signaling through its interaction with the IL-1 receptor-associated kinase 4 (IRAK4)-IRAK-tumor necrosis factor receptor-associated factor 6 (TRAF6) complex. J Biol Chem. 2003 Mar 28;278(13):10952-6.
|
REF 44 |
Caspase-4 interacts with TNF receptor-associated factor 6 and mediates lipopolysaccharide-induced NF-kappaB-dependent production of IL-8 and CC chemokine ligand 4 (macrophage-inflammatory protein-1 ). J Immunol. 2007 Dec 15;179(12):8480-90.
|
REF 45 |
Interleukin-1 (IL-1)-induced TAK1-dependent Versus MEKK3-dependent NFkappaB activation pathways bifurcate at IL-1 receptor-associated kinase modifi... J Biol Chem. 2007 Mar 2;282(9):6075-89.
|
REF 46 |
TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway. Mol Cell. 2000 Apr;5(4):649-58.
|
REF 47 |
Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR . J Biol Chem. 2003 May 9;278(19):16713-9.
|
REF 48 |
Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol Cell Biol. 2002 Oct;22(20):7158-67.
|
REF 49 |
The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature. 1999 Mar 18;398(6724):252-6.
|
REF 50 |
ASK1 inhibits interleukin-1-induced NF-kappa B activity through disruption of TRAF6-TAK1 interaction. J Biol Chem. 2000 Oct 20;275(42):32747-52.
|
REF 51 |
Two mechanistically and temporally distinct NF-kappaB activation pathways in IL-1 signaling. Sci Signal. 2009 Oct 20;2(93):ra66.
|
REF 52 |
The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors. Sci Signal. 2015 Jun 2;8(379):ra54.
|
REF 53 |
Role of the TAB2-related protein TAB3 in IL-1 and TNF signaling. EMBO J. 2003 Dec 1;22(23):6277-88.
|
REF 54 |
The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling. Nat Commun. 2016 Jun 1;7:11267.
|
REF 55 |
TRAF6 autoubiquitination-independent activation of the NFkappaB and MAPK pathways in response to IL-1 and RANKL. PLoS One. 2008;3(12):e4064.
|
REF 56 |
The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol. 2008 Oct;10(10):1199-207.
|
REF 57 |
Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex. Mol Endocrinol. 2006 Jul;20(7):1587-96.
|
REF 58 |
Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nat Immunol. 2011 Aug 7;12(9):853-60.
|
REF 59 |
Dysregulated Inflammatory Signaling upon Charcot-Marie-Tooth Type 1C Mutation of SIMPLE Protein. Mol Cell Biol. 2015 Jul;35(14):2464-78.
|
REF 60 |
BAT3 negatively regulates lipopolysaccharide-induced NF-B signaling through TRAF6. Biochem Biophys Res Commun. 2016 Sep 16;478(2):784-90.
|
REF 61 |
Direct activation of protein kinases by unanchored polyubiquitin chains. Nature. 2009 Sep 3;461(7260):114-9.
|
REF 62 |
TRAF6 mediates Smad-independent activation of JNK and p38 by TGF-beta. Mol Cell. 2008 Sep 26;31(6):918-24.
|
REF 63 |
TRAF6 promotes TGF-induced invasion and cell-cycle regulation via Lys63-linked polyubiquitination of Lys178 in TGF type I receptor. Cell Cycle. 2015;14(4):554-65.
|
REF 64 |
IRAK-2 participates in multiple toll-like receptor signaling pathways to NFkappaB via activation of TRAF6 ubiquitination. J Biol Chem. 2007 Nov 16;282(46):33435-43.
|
REF 65 |
TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell. 1999 Dec;4(6):1041-9.
|
REF 66 |
Src Family Kinases Regulate Interferon Regulatory Factor 1 K63 Ubiquitination following Activation by TLR7/8 Vaccine Adjuvant in Human Monocytes and B Cells. Front Immunol. 2018 Mar 1;9:330.
|
REF 67 |
TRAF6 protein couples Toll-like receptor 4 signaling to Src family kinase activation and opening of paracellular pathway in human lung microvascular endothelia. J Biol Chem. 2012 May 11;287(20):16132-45.
|
REF 68 |
FOSL1 Inhibits Type I Interferon Responses to Malaria and Viral Infections by Blocking TBK1 and TRAF3/TRIF Interactions. MBio. 2017 Jan 3;8(1). pii: e02161-16.
|
REF 69 |
MAVS activates TBK1 and IKK through TRAFs in NEMO dependent and independent manner. PLoS Pathog. 2017 Nov 10;13(11):e1006720.
|
REF 70 |
Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat Immunol. 2004 Jan;5(1):98-103.
|
REF 71 |
Role of growth arrest and DNA damage-inducible in Akt phosphorylation and ubiquitination after mechanical stress-induced vascular injury. Am J Respir Crit Care Med. 2011 Nov 1;184(9):1030-40.
|
REF 72 |
The E3 ligase TRAF6 regulates Akt ubiquitination and activation. Science. 2009 Aug 28;325(5944):1134-8.
|
REF 73 |
Cytokine-induced activation of mixed lineage kinase 3 requires TRAF2 and TRAF6. Cell Signal. 2009 Nov;21(11):1620-5.
|
REF 74 |
Lysine 63-linked ubiquitination modulates mixed lineage kinase-3 interaction with JIP1 scaffold protein in cytokine-induced pancreatic cell death. J Biol Chem. 2013 Jan 25;288(4):2428-40.
|
REF 75 |
Association between Presenilin-1 and TRAF6 modulates regulated intramembrane proteolysis of the p75NTR neurotrophin receptor. J Neurochem. 2009 Jan;108(1):216-30.
|
REF 76 |
Interleukin-1 receptor type 1 is a substrate for gamma-secretase-dependent regulated intramembrane proteolysis. J Biol Chem. 2009 Jan 16;284(3):1394-409.
|
REF 77 |
Presenilins are novel substrates for TRAF6-mediated ubiquitination. Cell Signal. 2013 Sep;25(9):1769-79.
|
REF 78 |
TRAF6 stimulates the tumor-promoting effects of TGF type I receptor through polyubiquitination and activation of presenilin 1. Sci Signal. 2014 Jan 7;7(307):ra2.
|
REF 79 |
Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation. EMBO J. 2007 Nov 14;26(22):4634-45.
|
REF 80 |
Protein kinase C- negatively regulates T cell receptor-induced NF-B activation by inhibiting the assembly of CARMA1 signalosome. J Biol Chem. 2012 Jun 8;287(24):20081-7.
|
REF 81 |
Ubiquitin-specific Protease 20 Regulates the Reciprocal Functions of -Arrestin2 in Toll-like Receptor 4-promoted Nuclear Factor B (NFB) Activation. J Biol Chem. 2016 Apr 1;291(14):7450-64.
|
REF 82 |
Ubiquitin-specific peptidase 20 targets TRAF6 and human T cell leukemia virus type 1 tax to negatively regulate NF-kappaB signaling. J Virol. 2011 Jul;85(13):6212-9.
|
REF 83 |
Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNF-induced cancer cell migration. Biochem J. 2012 Feb 1;441(3):979-86.
|
REF 84 |
Ubiquitin-specific protease 4 mitigates Toll-like/interleukin-1 receptor signaling and regulates innate immune activation. J Biol Chem. 2012 Mar 30;287(14):11002-10.
|
REF 85 |
Caspase-8 regulation by direct interaction with TRAF6 in T cell receptor-induced NF-kappaB activation. Curr Biol. 2006 Aug 22;16(16):1666-71.
|
REF 86 |
TRAF6 regulates cell fate decisions by inducing caspase 8-dependent apoptosis and the activation of NF-kappaB. J Biol Chem. 2006 Apr 21;281(16):11235-49.
|
REF 87 |
Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne. Nat Struct Mol Biol. 2010 Aug;17(8):939-47.
|
REF 88 |
A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains. J Biol Chem. 2001 Jun 29;276(26):24242-52.
|
REF 89 |
USP2a positively regulates TCR-induced NF-B activation by bridging MALT1-TRAF6. Protein Cell. 2013 Jan;4(1):62-70.
|
REF 90 |
Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol. 2004 Oct;5(10):1061-8.
|
REF 91 |
Guanylate binding protein 4 negatively regulates virus-induced type I IFN and antiviral response by targeting IFN regulatory factor 7. J Immunol. 2011 Dec 15;187(12):6456-62.
|
REF 92 |
TRAF6 and the three C-terminal lysine sites on IRF7 are required for its ubiquitination-mediated activation by the tumor necrosis factor receptor family member latent membrane protein 1. Mol Cell Biol. 2008 Oct;28(20):6536-46.
|
REF 93 |
TGF-1 inhibits the production of IFN in response to CpG DNA via ubiquitination of TNF receptor-associated factor (TRAF) 6. Innate Immun. 2015 Oct;21(7):770-7.
|
REF 94 |
TRAF6 upregulates expression of HIF-1 and promotes tumor angiogenesis. Cancer Res. 2013 Aug 1;73(15):4950-9.
|
REF 95 |
A hypoxia-responsive TRAF6-ATM-H2AX signalling axis promotes HIF1 activation, tumorigenesis andmetastasis. Nat Cell Biol. 2017 Jan;19(1):38-51.
|
REF 96 |
p62/SQSTM1 enhances NOD2-mediated signaling and cytokine production through stabilizing NOD2 oligomerization. PLoS One. 2013;8(2):e57138.
|
REF 97 |
TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol Cell. 2004 Aug 27;15(4):535-48.
|
REF 98 |
Gliotoxin suppresses NF-B activation by selectively inhibiting linear ubiquitin chain assembly complex (LUBAC). ACS Chem Biol. 2015 Mar 20;10(3):675-81.
|
REF 99 |
The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell. 2004 May 7;14(3):289-301.
|
REF 100 |
The activity of TRAF RING homo- and heterodimers is regulated by zinc finger 1. Nat Commun. 2017 Nov 27;8(1):1788.
|
REF 101 |
TRAF6-mediated ubiquitination of NEMO requires p62/sequestosome-1. Mol Immunol. 2014 Mar;58(1):27-31.
|
REF 102 |
Lack of interaction between NEMO and SHARPIN impairs linear ubiquitination and NF-B activation and leads to incontinentia pigmenti. J Allergy Clin Immunol. 2017 Dec;140(6):1671-1682.e2.
|
REF 103 |
SMN1 functions as a novel inhibitor for TRAF6-mediated NF-B signaling. Biochim Biophys Acta Mol Cell Res. 2017 May;1864(5):760-770.
|
REF 104 |
Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation. J Biol Chem. 2007 Feb 9;282(6):4102-12.
|
REF 105 |
The endoplasmic reticulum adaptor protein ERAdP initiates NK cell activation via the Ubc13-mediated NF-B pathway. J Immunol. 2015 Feb 1;194(3):1292-303.
|
REF 106 |
Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract. Nat Immunol. 2016 Dec;17(12):1373-1380.
|
REF 107 |
Tetraspanin 6 (TSPAN6) negatively regulates retinoic acid-inducible gene I-like receptor-mediated immune signaling in a ubiquitination-dependent manner. J Biol Chem. 2012 Oct 5;287(41):34626-34.
|
REF 108 |
VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell. 2005 Sep 16;19(6):727-40.
|
REF 109 |
UBXN1 interferes with Rig-I-like receptor-mediated antiviral immune response by targeting MAVS. Cell Rep. 2013 Apr 25;3(4):1057-70.
|
REF 110 |
Structural Insights into mitochondrial antiviral signaling protein (MAVS)-tumor necrosis factor receptor-associated factor 6 (TRAF6) signaling. J Biol Chem. 2015 Oct 30;290(44):26811-20.
|
REF 111 |
TRAF6-dependent Act1 phosphorylation by the IB kinase-related kinases suppresses interleukin-17-induced NF-B activation. Mol Cell Biol. 2012 Oct;32(19):3925-37.
|
REF 112 |
Syk mediates IL-17-induced CCL20 expression by targeting Act1-dependent K63-linked ubiquitination of TRAF6. J Invest Dermatol. 2015 Feb;135(2):490-498.
|
REF 113 |
NUMBL interacts with TRAF6 and promotes the degradation of TRAF6. Biochem Biophys Res Commun. 2010 Feb 12;392(3):409-14.
|
REF 114 |
Numbl inhibits glioma cell migration and invasion by suppressing TRAF5-mediated NF-B activation. Mol Biol Cell. 2012 Jul;23(14):2635-44.
|
REF 115 |
NUMBL Interacts with TAK1, TRAF6 and NEMO to Negatively Regulate NF-B Signaling During Osteoclastogenesis. Sci Rep. 2017 Oct 3;7(1):12600.
|
REF 116 |
A functional interaction between the p75 neurotrophin receptor interacting factors, TRAF6 and NRIF. J Biol Chem. 2004 Apr 16;279(16):16646-56.
|
REF 117 |
Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta. Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3533-8.
|
REF 118 |
The TLR signaling adaptor TRAM interacts with TRAF6 to mediate activation of the inflammatory response by TLR4. J Leukoc Biol. 2014 Sep;96(3):427-36.
|
REF 119 |
Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway. Mol Immunol. 2010 Mar;47(6):1283-91.
|
REF 120 |
CD40-mediated tumor necrosis factor receptor-associated factor 3 signaling upregulates IL-4-induced germline Cepsilon transcription in a human B cell line. Arch Biochem Biophys. 2002 Sep 15;405(2):199-204.
|
REF 121 |
Distinct molecular mechanism for initiating TRAF6 signalling. Nature. 2002 Jul 25;418(6896):443-7.
|
REF 122 |
The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol. 2010 Sep;11(9):836-45.
|
REF 123 |
TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J Exp Med. 2000 Jul 3;192(1):137-43.
|
REF 124 |
Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6. Mol Cell Biol. 2002 Feb;22(4):992-1000.
|
REF 125 |
Characterization of the intracellular domain of receptor activator of NF-kappaB (RANK). Interaction with tumor necrosis factor receptor-associated factors and activation of NF-kappab and c-Jun N-terminal kinase. J Biol Chem. 1998 Aug 7;273(32):20551-5.
|
REF 126 |
TIRP, a novel Toll/interleukin-1 receptor (TIR) domain-containing adapter protein involved in TIR signaling. J Biol Chem. 2003 Jul 4;278(27):24526-32.
|